Title of article :
Risk Factors of Recurrent Anal Abscess in Patients with Type 2 Diabetes Mellitus; a 4-Year Retrospective study
Author/Authors :
Malekpour Alamdari, Nasser Clinical Research and Development Center - Department of Surgery - Shahid Modarres Hospital - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Afaghi, Siamak Research Institute of Internal Medicine - Shahid Modarres Hospital - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Esmaeili Tarki, Farzad Research Institute of Internal Medicine - Shahid Modarres Hospital - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Fathi, Mohammad Critical Care Quality Improvement Research Center - Shahid Modarres Hospital - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Besharat, Sara Department of Radiology - Shahid Labbafinezhad Hospital - Shahid Beheshti University of Medical Sciences, Tehran, Iran , Rahimi, Fatemehsadat Clinical Research and Development Center - Department of Surgery - Shahid Modarres Hospital - Shahid Beheshti University of Medical Sciences, Tehran, Iran
Abstract :
Introduction: Anal abscess is considered as a relatively common compilation in type 2 diabetes mellitus (T2DM)
patients. This study aimed to determine the risk factors of recurrent anal abscess in T2DM patients. Methods: In
this 4-year retrospective cross-sectional study, T2DM patients hospitalized due to anal abscess in Shahid Modar-
res Hospital, Tehran, Iran from December 2016 to December 2020 were studied. The independent risk factors of
disease recurrence were determined among demographic factors, underlying diseases, diabetes-related factors,
clinical factors, laboratory parameters, abscess type, and culture using multivariate stepwise logistic regression
analysis. Results: 203 patients were enrolled in the study. 58 (28.6%) patients had at least one re-occurrence
of anal abscess during four years. The recurrent episodes had occurred more frequently in the first year after
the initial treatment (55.2%). The prevalence of comorbidities such as metabolic syndrome, coronary artery dis-
ease, chronic kidney disease, end stage renal disease, and peripheral vascular disease was significantly higher
amongst patients with abscess recurrence. The patients with recurrent anal abscess had statically significant
poor glycemic control (HbA1C > 7.5), decreased levels of Estimated Glomerular Filtration Rate (e-GFR), and
higher C-reactive Protein (CRP) upon the first admission. Presence of metabolic syndrome, HbA1c > 7.5%, WBC
> 11.0 ×109/L, and CRP > 5 mg/l were amongst the independent risk factors of recurrence. HbA1c > 7.5% was
the greatest independent risk factor of anal abscess recurrence (OR=2.68, 95% CI: 1.37-5.25; p < 0.001). The area
under the receiver operating characteristic (ROC) curve (AUC) of HbA1C, CRP, and WBC in predicting the risk of
abscess recurrence was 0.81, 0.71, and 0.64, respectively. Conclusion: Th recurrence rate of anal abscess in this
series was 28.6 %. It seems that in T2DM patients with uncontrolled diabetes who have metabolic syndrome
and increased CRP and WBC in their routine tests, the probability of anal abscess reoccurrence is high.
Keywords :
Diabetes mellitus , abscess , metabolic syndrome , leukocytosis , diabetes complications
Journal title :
Archives of Academic Emergency Medicine (AAEM)